SCAI Scientific Sessions 2025 to Feature Presentations on TAVR, PAD and PE
DAIC
MARCH 14, 2025
Washington Convention Center in Washington, DC.
52 
Forgotten IVC Filters Aren’t SAFE
CardiacWire
NOVEMBER 13, 2024
IVC filters are used to prevent pulmonary embolism in patients with venous thromboembolism and can’t receive anticoagulation treatment. Out of SAFE-IVC’s roughly 270k Medicare beneficiaries, only 15% had their IVC filters retrieved within 1.2 years of insertion. That number barely rose to 16.8%
Contemporary Administrative Codes to Identify Pulmonary Vein Isolation Procedures for Atrial Fibrillation
Journal of the American Heart Association
JANUARY 10, 2025
BackgroundUse of pulmonary vein isolation (PVI) to treat atrial fibrillation continues to increase. We identified 25 617 inpatient PVIs from January 2017 to December 2021, of which 18 165 (71%) were linked to Medicare Provider Analysis and Review. Journal of the American Heart Association, Ahead of Print.
CMS to cover implantable heart failure device
Becker's Hospital Review - Cardiology
JANUARY 13, 2025
"CMS proposes Medicare and Medicaid coverage for implantable pulmonary artery pressure sensors to manage heart failure. Final decision to be published on Jan.
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study
DAIC
MARCH 13, 2024
CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. ,
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
DAIC
MAY 2, 2024
a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the primary endpoint results of the open label roll-in cohort of the CardiAMP Cell Therapy in Chronic Myocardial Ischemia Trial. Getty Images milla1cf Thu, 05/02/2024 - 10:12 May 2, 2024 — BioCardia, Inc. ,
The Evolving Computed Tomography Market
DAIC
MARCH 7, 2024
Data was pulled from 2010–2019 Physician/Supplier Procedure Summary (PSPS) files obtained from the Centers for Medicare and Medicaid Services (CMS) website. According to the company, the Duo system adds high resolution thoracic clinical capability, suitable for screening lung cancer, COVID-19 and other pulmonary diseases.
Let's personalize your content